Randomized controlled trial compares sedative effects of remimazolam and midazolam in critically ill patients, indicating distinct extubation times.
A Correction on: Liu R, Su B, Gan G, Wang G, Wang C, Xu N, Feng G, Guo H, Yuan Q, Li A, Zheng W, Li J, Chen Y and Zhang X (2025) Effect of remimazolam besylate versus midazolam on time to extubation in critically ill, mechanically ventilated patients: a randomized controlled trial. Front. Med. 12:1553495. doi: 10.3389/fmed.2025.1553495 The incorrect citation was cited in Discussion, paragraph two. It should be reference 16 instead of 18. The corrected sentence appears below: "In accordance with previous studies (16), the goal of sedation target level was a RASS score of 0 to −3 after randomization." The incorrect citation was cited in Discussion, paragraph two. It should be reference 18 instead of 16. The corrected sentence appears below: "Considering the variations in sedation duration before randomization that might influence outcomes, we compared the sedation duration before randomization and found no statistical difference between the groups. Various physiological parameters, including age-related effects, compromised renal function, and liver dysfunction, may affect the pharmacokinetics of benzodiazepine medications (18)." The reference details for references 18 and 20 should be swapped. The correct references Spina et al. (18) and Sanavia et al. (20) appear below:
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: